🔎 Trials Near Me

ホーム › 脊髄性筋萎縮症 › テキサス

テキサスにおける脊髄性筋萎縮症の臨床試験

テキサス内の拠点で、脊髄性筋萎縮症に関する10件の研究が参加者を募集しています。

テキサス内の都市

公式研究テキスト(英語)

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

  • The University of Texas Southwestern Medical Center at Dallas, Dallas
  • Cook Children's Jane and John Justin Neurosciences Center, Fort Worth
被験者募集中第4相
3 Months – 24 Months · 全性別 · 2026/10/02更新 · NCT05861986

A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy

  • University of Texas Southwestern Medical Center, Dallas
  • Neurology Rare Disease Center, Flower Mound
  • Cook Children's Medical Center, Fort Worth
  • 他1件
被験者募集中第2相
2歳以下 · 全性別 · 2026/10/02更新 · NCT07047144

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

  • Neurology Rare Disease Center, Flower Mound
  • Texas Children's Hospital, Houston
被験者募集中第2相
5歳〜17歳 · 全性別 · 2026/09/14更新 · NCT07287982

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy

  • University of Texas Southwestern Medical Center, Dallas
被験者募集中第4相
3 Months – 24 Months · 全性別 · 2026/09/10更新 · NCT05861999

A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)

  • Texas Childrens Hospital Houston, Houston
被験者募集中第1相
3歳以上 · 全性別 · 2026/09/03更新 · NCT06555419

Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy

  • Texas Children's Hospital, Houston
被験者募集中
3歳以上 · 全性別 · 2026/08/19更新 · NCT05866419

A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

  • Neurology Rare Disease Center, Flower Mound
被験者募集中第3相
0 Days – 42 Days · 全性別 · 2026/08/18更新 · NCT07221669

A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec

  • Neurology Rare Disease Center, Flower Mound
被験者募集中第3相
0 Days – 7 Months · 全性別 · 2026/08/11更新 · NCT07444450

Clinical Procedures to Support Research in ALS

  • University of Texas San Antonio Health Science Center, San Antonio
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/15更新 · NCT03489278

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

  • Cook Children's, Fort Worth
  • Texas Children's Hospital, Houston
  • CHRISTUS Health, San Antonio
被験者募集中観察研究
全年齢 · 全性別 · 2025/01/31更新 · NCT04174157

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。